SCHEDULE 13G/A
0001193125-24-091977
0001863769
XXXXXXXX
LIVE
1
Common Stock
12/31/2024
0001880438 AN2 THERAPEUTICS, INC. 037326105
1800 El Camino Real, Suite D
Menlo Park
CA
94027
Rule 13d-1(c)
Frazier Life Sciences Public Fund, L.P.
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLSP, L.P.
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLSP, L.L.C.
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
Frazier Life Sciences X, L.P.
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS X, L.P.
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS X, L.L.C.
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
Frazier Life Sciences XI, L.P.
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS XI, L.P.
DE
0.00
0.00
0.00
0.00
0.00
0.0
PN
FHMLS XI, L.L.C.
DE
0.00
0.00
0.00
0.00
0.00
0.0
OO
James N. Topper
b
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Patrick J. Heron
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Albert Cha
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
James Brush
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
Daniel Estes
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
AN2 THERAPEUTICS, INC.
1800 El Camino Real, Suite D , Menlo Park, CA, 94027.
The entities and persons filing this statement (collectively, the "Reporting Persons") are:
Frazier Life Sciences Public Fund, L.P. ("FLSPF")
FHMLSP, L.P.
FHMLSP, L.L.C.
Frazier Life Sciences XI, L.P. ("FLS XI")
FHMLS XI, L.P.
FHMLS XI, L.L.C.
Frazier Life Sciences X, L.P. ("FLS X")
FHMLS X, L.P.
FHMLS X, L.L.C.
James N. Topper ("Topper")
Patrick J. Heron ("Heron")
Albert Cha ("Cha")
James Brush ("Brush")
Daniel Estes ("Estes" and together with Topper, Heron, Cha and Brush, the "Members") The address and principal business office of the Reporting Persons is:
c/o Frazier Life Sciences Management, L.P.
1001 Page Mill Rd, Building 4, Suite B
Palo Alto, CA 94304 Entities: FLSPF - Delaware, U.S.A.
FHMLSP, L.P. - Delaware, U.S.A.
FHMLSP, L.L.C. - Delaware, U.S.A.
FLS XI - Delaware, U.S.A.
FHMLS XI, L.P. - Delaware, U.S.A.
FHMLS XI, L.L.C. - Delaware, U.S.A.
FLS X - Delaware, U.S.A.
FHMLS X, L.P. - Delaware, U.S.A.
FHMLS X, L.L.C. - Delaware, U.S.A.
Individuals: Topper - United States Citizen
Heron - United States Citizen
Cha - United States Citizen
Brush - United States Citizen
Estes - United States Citizen
Y
The information contained in row 9 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference. The information contained in row 11 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 5 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 6 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 7 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
The information contained in row 8 of each Reporting Person's cover page to this Schedule 13G is incorporated by reference.
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Exhibit 99.1 Joint Filing Agreement
Frazier Life Sciences Public Fund, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
02/14/2025
FHMLSP, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
02/14/2025
FHMLSP, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLSP, L.L.C.
02/14/2025
Frazier Life Sciences X, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
02/14/2025
FHMLS X, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
02/14/2025
FHMLS X, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS X, L.L.C.
02/14/2025
Frazier Life Sciences XI, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
02/14/2025
FHMLS XI, L.P.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
02/14/2025
FHMLS XI, L.L.C.
/s/ Steve R. Bailey
By Steve R. Bailey, CFO of FHMLS XI, L.L.C.
02/14/2025
James N. Topper
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
02/14/2025
Patrick J. Heron
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
02/14/2025
Albert Cha
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
02/14/2025
James Brush
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
02/14/2025
Daniel Estes
/s/ Steve R. Bailey
By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022
02/14/2025